Document:

Exhibit 10.1

 

THIS
WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY
NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT
UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO SANSAL WELLNESS HOLDINGS,
INC. THAT SUCH REGISTRATION IS NOT REQUIRED OR THE SALE OF SUCH SECURITIES IS MADE PURSUANT TO SEC RULE 144. 

 

Right
to Purchase up to ________ Shares of Common Stock of 

SanSal Wellness Holdings, Inc. 

(subject to adjustment as provided herein)

 

COMMON
STOCK PURCHASE WARRANT 

 

	No. ___	Original
    Issue Date: _____________, 2018

 

SANSAL
WELLNESS HOLDINGS, INC., a Nevada corporation (“SanSal” or the “Company”), hereby certifies
that, for value received, _________________________, or permitted assigns (the “Holder”), is entitled,
subject to the terms set forth below, to purchase from the Company (as defined herein) from and after the Original Issue Date
of this Warrant and at any time or from time to time before 5:00 p.m., New York time, through the close of business on the fifth
(5th) anniversary of the Original Issue Date (the “Expiration Date”), up to _____________ fully
paid and nonassessable shares of Common Stock (as hereinafter defined), $0.001 par value per share, at the applicable Exercise
Price per share (as defined below). The number and character of such shares of Common Stock and the applicable Exercise Price
per share are subject to adjustment as provided herein.

 

As
used herein the following terms, unless the context otherwise requires, have the following respective meanings:

 

(a)
       The terms “SanSal and the “Company” shall include SanSal
and any corporation which shall succeed, or assume the obligations of, SanSal hereunder.

 

(b)
       The term “Business Day’ shall mean any day other than Saturday, Sunday
or such other day as banks in New York, New York are permitted to be closed for business.

 

(c)
       The term “Common Stock” includes (i) the Company's Common Stock,
par value $0.001 per share; and (ii) any other securities into which or for which any of the securities described in the preceding
clause (i) may be converted or exchanged pursuant to a plan of recapitalization, reorganization, merger, sale of assets
or otherwise.

 

(d)
       The term “Exercise Price” shall mean Fifteen Cents ($0.15) per share
as of the Original Issue Date, subject to adjustment as provided herein.

 

     

     

    

 

(e)
       The term “Other Securities” refers to any stock (other than
Common Stock) and other securities of the Company or any other person (corporate or otherwise) which the holder of the
Warrant at any time shall be entitled to receive, or shall have received, on the exercise of the Warrant, in lieu of or in
addition to Common Stock, or which at any time shall be issuable or shall have been issued in exchange for or in replacement
of Common Stock or Other Securities pursuant to Section 4 or otherwise.

 

		1.	Exercise
                                         of Warrant.

 

1.11     
Number of Shares Issuable upon Exercise.  From and after the date hereof through and including the Expiration
Date, the Holder shall be entitled to receive, upon exercise of this Warrant in whole or in part, by delivery of an original,
facsimile, .PDF or other electronically transmitted copy of an exercise notice in the form attached hereto as Exhibit A
(the “Exercise Notice”), shares of Common Stock of the Company, subject to adjustment pursuant to Section
4.

 

1.12     
Fair Market Value. For purposes hereof, the “Fair Market Value” of a share of Common Stock as
of a particular date (the “Determination Date”) shall mean:

 

(a)
       If the Common Stock is listed on one or more established stock exchanges or national
market systems, including without limitation The NASDAQ Global Select Market, The NASDAQ Global Market, The NASDAQ Capital Market
of The NASDAQ Stock Market LLC, the New York Stock Exchange or the NYSE MKT, its Fair Market Value shall be the closing sales
price for such stock (or the closing bid, if no sales were reported) as quoted on the principal exchange or system on which the
Common Stock is listed on the Determination Date (or, if no closing sales price or closing bid was reported on that date, as applicable,
on the last trading date such closing sales price or closing bid was reported).

 

(b)
       If the Common Stock is regularly quoted on an automated quotation system (including
applicable tiers of the over-the-counter market maintained by OTC Markets Group, Inc.) or by a recognized securities dealer, its
Fair Market Value shall be the closing sales price for such stock as quoted on such system or by such securities dealer on the
Determination Date, but if selling prices are not reported, the Fair Market Value of a share of Common Stock shall be the mean
between the high bid and low asked prices for the Common Stock on the Determination Date (or, if no such prices were reported
on that date, on the last date such prices were reported) or the average thereof for such period prior to Determination Date.

 

(c)
       Except as provided in subsection 1.2(d), if the Company's Common Stock is not
publicly traded, then as the Holder and the Company agree or in the absence of such agreement by arbitration in accordance with
the rules then in effect of the American Arbitration Association, before a single arbitrator to be chosen by the Holder and the
Company from a panel of persons qualified by education and training to pass on the matter to be decided.

 

(d)
       If the Determination Date is the date of a liquidation, dissolution or winding up, or
any event deemed to be a liquidation, dissolution or winding up pursuant to SanSal’s charter, then all amounts to be payable
per share to holders of the Common Stock pursuant to the charter in the event of such liquidation, dissolution or winding up,
plus all other amounts to be payable per share in respect of the Common Stock in liquidation under the charter, assuming for the
purposes of this subsection 1.2(d), that all of the shares of Common Stock then issuable upon exercise of the Warrant are
outstanding at the Determination Date.

 

     

     

    

 

1.13      Company
Acknowledgment.  SanSal will, at the time of the exercise of the Warrant, upon the request of the holder hereof acknowledge
in writing its continuing obligation to afford to such holder any rights to which such holder shall continue to be entitled after
such exercise in accordance with the provisions of this Warrant. If the Holder shall fail to make any such request, such failure
shall not affect the continuing obligation of the Company to afford to such holder any such rights.

 

		2.	Procedure
                                         for Exercise.

 

2.1
      Delivery of Stock Certificates, Etc., on Exercise. The Company agrees that the
shares of Common Stock purchased upon exercise of this Warrant shall be deemed to be issued to the Holder as the record owner
of such shares as of the close of business on the date on which this Warrant shall have been surrendered and payment made for
such shares in accordance herewith. As soon as practicable after the exercise of this Warrant in full or in part, and in any event
within three (3) Business Days thereafter, the Company at its expense (including the payment by it of any applicable issue taxes)
will cause to be issued in the name of and delivered to the Holder, or as such Holder (upon payment by such Holder of any applicable
transfer taxes) may direct in compliance with applicable securities laws, a certificate or certificates for the number of duly
and validly issued, fully paid and nonassessable shares of Common Stock (or Other Securities) to which such Holder shall be entitled
on such exercise, plus, in lieu of any fractional share to which such holder would otherwise be entitled, cash equal to such fraction
multiplied by the then Fair Market Value of one full share, together with any other stock or other securities and property (including
cash, where applicable) to which such Holder is entitled upon such exercise pursuant to Section 1 or otherwise.

 

2.2
      Exercise.  Payment may be made to the Company either by (a) cashier’s
check payable to the order of the Company equal to the applicable aggregate Exercise Price; or (b) wire transfer in immediately
available funds of the applicable aggregate Exercise Price in accordance with wire transfer instructions furnished by the Company
(as such exercise number shall be adjusted to reflect any adjustment in the total number of shares of Common Stock issuable to
the Holder per the terms of this Warrant) and the Holder shall thereupon be entitled to receive the number of duly authorized,
validly issued, fully-paid and non-assessable shares of Common Stock (or Other Securities) determined as provided herein.

 

		3.	Effect
                                         of Reorganization, Etc.; Adjustment of Exercise Price.

 

3.1
       Reorganization, Consolidation, Merger and Similar Recapitalizations. In
case at any time or from time to time, the Company shall (a) effect a reorganization; (b) consolidate with or merge into any other
person; or (c) transfer all or substantially all of its properties or assets to any other person under any plan or arrangement
contemplating the dissolution of the Company, then, in each such case, as a condition to the consummation of such a transaction,
proper and adequate provision shall be made by the Company whereby the Holder of this Warrant, on the exercise hereof as provided
in Section 1 at any time after the consummation of such reorganization, consolidation or merger or the effective date of
such dissolution, as the case may be, shall receive, in lieu of the Common Stock (or Other Securities) issuable on such exercise
prior to such consummation or such effective date, the stock and other securities and property (including cash) to which such
Holder would have been entitled upon such consummation or in connection with such dissolution, as the case may be, if such Holder
had so exercised this Warrant, immediately prior thereto, all subject to further adjustment thereafter as provided in Section
4.

 

     

     

    

 

3.2
         Dissolution. In the event of any dissolution of SanSal following
the transfer of all or substantially all of its properties or assets, the Company, concurrently with any distributions made to
holders of its Common Stock, shall at its expense deliver or cause to be delivered to the Holder the stock and other securities
and property (including cash, where applicable) receivable by the Holder of the Warrant pursuant to Section 3.1.

 

3.3      
Continuation of Terms.  Upon any reorganization, consolidation, merger or transfer (and any dissolution following
any transfer) referred to in this Section 3, this Warrant shall continue in full force and effect and the terms hereof
shall be applicable to the shares of stock and other securities and property receivable on the exercise of this Warrant after
the consummation of such reorganization, consolidation or merger or the effective date of dissolution following any such transfer,
as the case may be, and shall be binding upon the issuer of any such stock or other securities, including, in the case of any
such transfer, the person acquiring all or substantially all of the properties or assets of the Company, whether or not such person
shall have expressly assumed the terms of this Warrant as provided in Section 4. In the event this Warrant does not continue in
full force and effect after the consummation of the transactions described in this Section 3, then the Company's securities
and property (including cash, where applicable) receivable by the Holder.

 

4.            Extraordinary
Events Regarding Common Stock.  In the event that the Company shall (a) issue additional shares of the Common Stock
as a dividend or other distribution on outstanding Common Stock; (b) subdivide its outstanding shares of Common Stock; or (c)
combine its outstanding shares of the Common Stock into a smaller number of shares of the Common Stock, then, in each such event,
the Exercise Price shall, simultaneously with the happening of such event, be adjusted by multiplying the then Exercise Price
by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately prior to such event
and the denominator of which shall be the number of shares of Common Stock outstanding immediately after such event, and the product
so obtained shall thereafter be the Exercise Price then in effect. The Exercise Price, as so adjusted, shall be readjusted in
the same manner upon the happening of any successive event or events described herein in this Section 4. The number of
shares of Common Stock that the holder of this Warrant shall thereafter, on the exercise hereof as provided in Section 1, be entitled
to receive shall be increased to a number determined by multiplying the number of shares of Common Stock that would otherwise
(but for the provisions of this Section 4) be issuable on such exercise by a fraction of which (a) the numerator is the
Exercise Price that would otherwise (but for the provisions of this Section 4) be in effect; and (b) the denominator is
the Exercise Price in effect on the date of such exercise.

 

5.
            Reservation of Stock, Etc., Issuable on Exercise
of Warrant. SanSal will at all times reserve and keep available, solely for issuance and delivery on the exercise of the
Warrant, shares of Common Stock (or Other Securities) from time to time issuable on the exercise of the Warrant.

 

     

     

    

 

6.          
 Assignment; Exchange of Warrant.  Subject to compliance with applicable securities laws, this Warrant,
and the rights evidenced hereby, may be transferred by the Holder (a “Transferor”) in whole or in part. On
the surrender for exchange of this Warrant, with the Transferor's endorsement in the form of Exhibit B attached hereto
(the “Transferor Endorsement Form”) and together with evidence reasonably satisfactory to the Company demonstrating
compliance with applicable securities laws, which shall include, without limitation, the provision of a legal opinion from the
Transferor's counsel (at the Transferor’s expense) that such transfer is exempt from the registration requirements of applicable
securities laws, and with payment by the Transferor of any applicable transfer taxes) will issue and deliver to or on the order
of the Transferor thereof a new Warrant of like tenor, in the name of the Transferor and/or the transferee(s) specified in such
Transferor Endorsement Form, calling in the aggregate on the face or faces thereof for the number of shares of Common Stock called
for on the face or faces of the Warrant so surrendered by the Transferor.

 

7.
            Replacement of Warrant. On receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of any such
loss, theft or destruction of this Warrant, on delivery of an indemnity agreement or security reasonably satisfactory in form
and amount to the Company or, in the case of any such mutilation, on surrender and cancellation of this Warrant, the Company at
its expense will execute and deliver, in lieu thereof, a new Warrant of like tenor.

 

8.
            Transfer on the Company's Books.  Until
this Warrant is transferred on the books of the Company, the Company may treat the registered Holder hereof as the absolute owner
hereof for all purposes, notwithstanding any notice to the contrary.

 

9.
            Notices, Etc. All notices and other communications
from the Company to the Holder of this Warrant shall be mailed by certified mail, postage prepaid, at such address as may have
been furnished to the Company in writing by such Holder or, until any such Holder furnishes to the Company an address, then to,
and at the address of, the last Holder of this Warrant who has so furnished an address to the Company.

 

10.
          Compliance with Securities Laws. By acceptance of this
Warrant, the Holder hereby represents, warrants and covenants that any shares of stock purchased upon exercise of this Warrant
shall be acquired for investment only and not with a view to, or for sale in connection with, any distribution thereof; that the
Holder has had such opportunity as such Holder has deemed adequate to obtain from representatives of the Company such information
as is necessary to permit the Holder to evaluate the merits and risks of its investment in the Company; that the Holder is able
to bear the economic risk of holding such shares as may be acquired pursuant to the exercise of this Warrant for an indefinite
period; that the Holder understands that the shares of stock acquired pursuant to the exercise of this Warrant will not be registered
under the Securities Act (unless otherwise required pursuant to exercise by the Holder of the registration rights, if any, granted
to the Registered Holder) and will be “restricted securities” within the meaning of Rule 144 under the Securities
Act and that the exemption from registration under Rule 144 will not be available for up to one (1) year from the date of exercise
of this Warrant, and even then will not be available unless a public market then exists for the stock, adequate information concerning
the Company is then available to the public, and other terms and conditions of Rule 144 are complied with; and that all stock
certificates representing shares of stock issued to the Holder upon exercise of this Warrant or upon conversion of such shares
may have affixed thereto a legend substantially in the following form:

 

     

     

    

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND
RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT
TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS
INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE
SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE
STATE SECURITIES LAWS.

 

11.          
Registration Rights. All shares of Common Stock or Other Securities issuable upon exercise of this Warrant shall
be “Registrable Securities” or such other definition of securities entitled to registration rights under the
Subscription Agreement pursuant to which this Warrant was originally sold and issued by the Company and the accompanying Registration
Rights Agreement.

 

12.
          Representations and Warranties of the Company.      The
Company hereby represents and warrants to Holder that:

 

12.1    
Due Authorization; Consents.  All corporate action on the part of the Company, its officers, directors and
shareholders necessary for (a) the authorization, execution and delivery of, and the performance of all obligations of the Company
under, this Warrant, and (b) the authorization, issuance, reservation for issuance and delivery of all of the Common Stock issuable
upon exercise of this Warrant, has been duly taken. This Warrant constitutes a valid and binding obligation of the Company enforceable
in accordance with its terms, subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, moratorium, reorganization
and similar laws affecting creditors’ rights generally and to general equitable principles. All consents, approvals and
authorizations of, and registrations, qualifications and filings with, any federal or state governmental agency, authority or
body, or any third party, required in connection with the execution, delivery and performance of this Warrant and the consummation
of the transactions contemplated hereby and thereby have been obtained.

 

12.2
    Organization.  The Company is a corporation duly organized, validly existing
and in good standing under the laws of the State of Nevada and has all requisite corporate power to own, lease and operate its
property and to carry on its business as now being conducted and as currently proposed to be conducted.

 

     

     

    

 

12.3
    Valid Issuance of Stock.  The outstanding shares of the capital stock of the Company
are duly and validly issued, fully paid and nonassessable, and such shares, and all outstanding options and other securities of
the Company, have been issued in full compliance with the registration and prospectus delivery requirements of the Securities
Act and the registration and qualification requirements of all applicable state securities laws, or in compliance with applicable
exemptions therefrom, and all other provisions of applicable federal and state securities laws, including without limitation,
anti-fraud provisions.

 

13.
          No Impairment.  The Company will not, by amendment
of its Articles of Incorporation or bylaws, or through reorganization, consolidation, merger, dissolution, issue or sale of securities,
sale of assets or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action
as may be necessary or appropriate in order to protect the rights of the Holder of this Warrant against impairment. Without limiting
the generality of the foregoing, the Company (a) will not increase the par value of any shares of stock issuable upon the exercise
of this Warrant above the amount payable therefor upon such exercise, and (b) will take all such action as may be necessary or
appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon exercise
of this Warrant.

 

14.
          Miscellaneous.  This Warrant and any term hereof
may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement
of such change, waiver, discharge or termination is sought. This Warrant shall be governed by and construed in accordance with
the laws of State of Nevada without regard to principles of conflicts of laws. Any action brought to interpret, enforce or otherwise
arising from this Warrant and the transactions contemplated by this Warrant, shall be brought only in a federal or state courts
of competent jurisdiction in any state, county, or federal district in which there is personal jurisdiction over the Company,
which submits to jurisdiction in any location in which it sells this Warrant. In any action brought to interpret, enforce or otherwise
arising from this Warrant and the transactions contemplated by this Warrant, the prevailing party shall be entitled to recover
from the other party its reasonable attorney's fees and costs at both the trial and appellate levels. In the event that any provision
of this Warrant is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative
to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such
provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other
provision of this Warrant. The headings in this Warrant are for purposes of reference only, and shall not limit or otherwise affect
any of the terms hereof. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability
of any other provision hereof.

 

[SIGNATURE
PAGE FOLLOWS] 

 

     

     

    

 

IN WITNESS WHEREOF, the Company
has executed this Warrant as of the date first written above. 

	 	 	 
	 	SANSAL WELLNESS HOLDINGS, INC.
	 	 	 
	 	By:	 
	 	 	Alexander M. Salgado, CEO

 

     

     

    

EXHIBIT A 

 

EXERCISE NOTICE 

(To Be Signed Only On Exercise Of Warrant)

 

	TO:	SANSAL WELLNESS HOLDINGS, INC.
	 	Attention:	Chief Executive Officer 

 

The undersigned, pursuant
to the provisions set forth in the attached Warrant (No.____), hereby irrevocably elects to purchase _________________ shares of
the Common Stock covered by such Warrant.

 

The undersigned herewith
makes payment of the full Exercise Price for such shares at the price per share provided for in such Warrant, which is $___________.
Such payment takes the form of a (check applicable box):

 

_____ Cashier’s check payable to the order of
the Company’ or

 

_____ Wire transfer in immediately available
funds in accordance with wire transfer instructions furnished by the Company.

 

The undersigned requests
that the certificates for such shares be issued in the name of, and delivered to ______________________________________________
whose address is _____________________________________________________________________.

 

The undersigned represents
and warrants that all offers and sales by the undersigned of the securities issuable upon exercise of the within Warrant shall
be made pursuant to registration of the Common Stock under the Securities Act of 1933, as amended (the “Securities Act”)
or pursuant to an exemption from registration under the Securities Act. 

	 	 	 	 
	Dated:	 	 	 
	 	 	 	(Signature must conform to name of holder as specified on the face of the Warrant)

 

	 	Address:	 
	 	 	 

 

     

     

    

EXHIBIT B 

 

FORM OF TRANSFEROR ENDORSEMENT 

(To Be Signed Only On Transfer Of Warrant)

 

For value received,
the undersigned hereby sells, assigns, and transfers unto the person(s) named below under the heading “Transferees”
the right represented by the within Warrant to purchase the percentage and number of shares of Common Stock of SanSal Wellness
Holdings, Inc., a Nevada corporation (the “Company”), into which the within Warrant relates specified under
the headings “Percentage Transferred” and “Number Transferred,” respectively, opposite the
name(s) of such person(s) and appoints each officer of the Company, as attorney-in-fact to transfer the Warrant on the books of
the Company with full power of substitution in the premises. 

	 	 	 	 	 	 	 
	 	 	 	 	Percentage	 	Number
	Transferees	 	Address	 	Transferred	 	Transferred
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 

	Dated:	 	 	 
	 	 	 	(Signature must conform to name of holder as specified on the face of the Warrant)

	 	 	 	 
	 	 	Address:	 
	 	 	 	 
	 	 	 	 
	 	 	 	 

	 	 	SIGNED IN THE PRESENCE OF:
	 	 	 	 
	 	 	 	 
	 	 	(Name)

	ACCEPTED AND AGREED:	 
	 	 	 	 
	TRANSFEREE:	 
	 	 	 	 
	(Name)Exhibit 10.2

 

REGISTRATION
RIGHTS AGREEMENT 

 

This
REGISTRATION RIGHTS AGREEMENT, dated as of _________ (this “Agreement”), among SANSAL WELLNESS HOLDINGS,
INC., a Nevada corporation (the “Company”), and _________ (the “Purchaser”).

 

INTRODUCTION

 

This
Agreement is made pursuant to the Subscription Agreement and sets forth the rights of the Purchaser to have registered, and the
obligations of the Company to register, under the Securities Act of 1933, as amended (the “Securities Act”),
the Registrable Securities (as defined below).

 

NOW,
THEREFORE, in consideration of the mutual promises, representations, warranties and covenants hereinafter set forth and for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree
as follows:

 

Section
1      Definitions. Capitalized terms used, but not otherwise defined herein that are defined
in the Subscription Agreement shall have the respective meanings given such terms in the Subscription Agreement. As used in this
Agreement, the following terms shall have the following meanings:

 

“Advice”
shall have the meaning set forth in Section 6(d).

 

“Effectiveness
Period” shall have the meaning set forth in Section 2(a).

 

“Event”
shall have the meaning set forth in Section 2(b).

 

“Event
Date” shall have the meaning set forth in Section 2(b).

 

“Filing
Date” means, with respect to the Registration Statement required pursuant to Section 3(c), the earliest practical
date on which the Company is permitted by SEC Guidance to file such Registration Statement related to the Registrable Securities,
but not more than ninety (90) days following the final closing of the Offering.

 

“Holder”
means the Purchaser.

 

“Indemnified
Party” shall have the meaning set forth in Section 5(c).

 

“Indemnifying
Party” shall have the meaning set forth in Section 5(c).

 

“Losses”
shall have the meaning set forth in Section 5(a).

 

“Offering”
shall mean that offering of Units pursuant to the Company’s Confidential Private Placement Memorandum dated May 30, 2018.

 

“Plan
of Distribution” shall have the meaning set forth in Section 2(a).

 

     1

    

    

 

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering
of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by
reference in such Prospectus.

 

“Registrable
Securities” shall mean, as of any date of determination, (a) all of the Shares (i) included in the Units (“Shares”)
and (ii) issuable upon exercise of the Warrants included in the Units (the “Warrant Shares”); and (b) any securities
issued or then issuable upon any stock split with respect to the foregoing; provided, however, that any such Registrable Securities
shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of the Registration
Statement hereunder with respect thereto) in the event that (1) such Registrable Securities have been disposed of by the Investor
or such other person to whom an Investor has transferred Registrable Securities (a “Holder”) in accordance
with the Registration Statement, (2) such Registrable Securities have been sold, or (3) the maximum length of time that the Company
can maintain the effectiveness of the Registration Statement has expired.

 

“Registration
Statement” means the registration statement required to be filed hereunder and any additional registration statements
contemplated by Section 3(c), including (in each case) the Prospectus, amendments and supplements to such registration
statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by
reference or deemed to be incorporated by reference in such registration statement.

 

“Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.

 

“Selling
Shareholder Questionnaire” shall have the meaning set forth in Section 3(a).

 

“SEC
Guidance” means (a) any publicly-available written or oral guidance, comments, requirements or requests of the Commission
staff; and (b) the Securities Act.

 

     2

    

    

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE AMEX, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange, the OTC Bulletin Board, the OTCQX maintained by OTC Markets, Inc., or the OTCQB maintained by OTC Markets,
Inc. (or any successors to any of the foregoing).

 

Section
2      Registration. 

 

(a)     
On or prior to the Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering, among
other things, the resale of all or such portion (as permitted by SEC Guidance and Rule 415) of the Registrable Securities on such
Filing Date that are not then registered on an effective Registration Statement. The Registration Statement shall be on Form S-1
and shall contain substantially the “Plan of Distribution” attached hereto as Annex A. Subject to the
terms of this Agreement, the Company shall use its commercially reasonable best efforts to have the Registration Statement declared
effective within ninety (90) days after the Registration Statement is filed, and shall use its commercially reasonable best efforts
to keep such Registration Statement continuously effective under the Securities Act until the earlier of (a) three years from
the Effectiveness Date; or (b) the date all Registrable Securities covered by such Registration Statement have been sold (the
“Effectiveness Period”).

 

(b)     
If: (i) the Registration Statement is not filed on or prior to its Filing Date, or (ii) the Company fails to file with the
Commission a request for acceleration in accordance with Rule 461 promulgated under the Securities Act, within five (5)
Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that the
Initial Registration Statement will not be “reviewed” or not be subject to further review, or (iii) the
Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in
respect of such Registration Statement within thirty (30) Trading Days after the receipt of comments by or notice from the
Commission that such amendment is required in order for such Initial Registration Statement to be declared effective, or (iv)
after the Effectiveness Date of a Registration Statement, such Registration Statement ceases for any reason to remain
continuously effective as to all Registrable Securities included in such Registration Statement, or the Holder is otherwise
not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive
calendar days or more than an aggregate of twenty (20) calendar days during any twelve (12) month period (which need not be
consecutive calendar days) (any such failure or breach being referred to as an “Event”, and for purposes
of clause (i), the date on which such Event occurs, or for purposes of clause (ii) the date on which such five (5) Trading
Day period is exceeded, or for purposes of clause (iii) the date which such twenty (20) Trading Day period is exceeded, or
for purposes of clause, as applicable, is exceeded being referred to as “Event Date”), then, in addition
to any other rights the Holder may have hereunder or under applicable law, on each such Event Date and on each monthly
anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable
Event is cured, the Company shall pay to the Holder an amount in cash, as partial liquidated damages and not as a penalty,
equal to $500 per month (not to exceed an aggregate of $5,000), pro-rated for periods of less than thirty (30) days. If the
Company fails to pay any partial liquidated damages pursuant to this Section in full within seven (7) days after the
date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is
permitted to be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due
until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms
hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event. If the Company fails
to file the Registration Statement on or before the Filing Date, the exercise price of the Warrant issued in the Offering
shall be adjusted downward from $0.15 to $0.10 per share.

 

     3

    

    

 

(c)     
The Company shall notify the Holder of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii)
through (vi) hereof, be accompanied by an instruction to suspend the use of the Registration Statement until the requisite
changes have been made and which notice shall be made by public dissemination of information by filing a Report on Form 8-K
or otherwise) as promptly as reasonably possible (and, in the case of (i)(A) below, not less than one Trading Day prior to
such filing) and (if requested by any such Person) confirm such notice in writing no later than one Trading Day following the
day (i)(A) when a Registration Statement or any supplement or post-effective amendment to a Registration Statement is
proposed to be filed; (B) when the Commission notifies the Company whether there will be a “review” of such
Registration Statement and whenever the Commission comments in writing on such Registration Statement; and (C) with respect
to a Registration Statement or any post-effective amendment, when the same has become effective; (ii) of any request by the
Commission or any other Federal or state governmental authority for amendments or supplements to a Registration Statement or
for additional information; (iii) of the issuance by the Commission or any other federal or state governmental authority of
any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or
the initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect to
the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any
jurisdiction, or the initiation or threatening of any Proceeding for such purpose; (v) of the occurrence of any event or
passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or
any statement made in a Registration Statement or any document incorporated or deemed to be incorporated therein by reference
untrue in any material respect or that requires any revisions to a Registration Statement or other documents so that, in the
case of a Registration Statement, it will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading; and (vi) the occurrence or existence of any pending corporate development with respect
to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the
best interest of the Company to allow continued availability of a Registration Statement, provided that any and all of such
information shall remain confidential to the Holder until such information otherwise becomes public, unless disclosure by the
Holder is required by law; provided, further, that notwithstanding the Holder’s agreement to keep such
information confidential, the Holder makes no acknowledgement that any such information is material, non-public
information.

 

     4

    

    

 

(d)     
In the event that the SEC shall seek to impose a limitation on the number of Registrable Securities that may be included in the
Registration Statement as a secondary offering pursuant to Rule 415 under the Securities Act or otherwise, the Company shall include
in such registration (i) first, the Registrable Securities, reduced, pro rata, among the Holders; and (ii) second, any
Company securities owned by other owners who have requested registration, reduced as determined by the Company.

 

(e)     
Once the SEC has declared the Registration Statement effective, the Company shall use its commercially reasonable efforts to maintain
the effectiveness of such Registration Statement during the Effectiveness Period and shall use its commercially reasonable efforts
to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order suspending the effectiveness of the Registration
Statement or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for
sale in any jurisdiction, at the earliest practicable moment.

 

(f)     
The Company shall promptly deliver to each Holder, without charge, as many copies of the Prospectus and each amendment or supplement
thereto as such Holders may reasonably request in connection with resales by the Holder of Registrable Securities.

 

(g)     
The Company shall use its commercially reasonable efforts to register or qualify or cooperate with the selling Holders in connection
with the registration or qualification (or exemption from the registration or qualification) of such Registrable Securities for
the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably
requests in writing, to keep each of the registration or qualification (or exemption therefrom) effective during the Effectiveness
Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.

 

(h)     
Upon learning that a prospectus that is part of the Registration Statement contains a material misstatement or omission that
causes other statements made therein to be materially inaccurate, as promptly as reasonably possible, the Company shall
notify the Holders to cease selling Registrable Securities and shall prepare a supplement or amendment, including a post-
effective amendment, to the Registration Statement or a supplement to the related prospectus, and file any other required
document so that, as thereafter delivered, neither the Registration Statement nor such prospectus will contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading. Each Holder agrees to cease
selling Registrable Securities immediately upon notice from the Company that the prospectus related to the Registrable
Securities is not current and not to resume selling Registrable Securities until notified by the Company that he or she may
do so.

 

     5

    

    

 

(i)      In order for a Holder to include Registrable Securities in the Registration Statement, each Holder must complete and execute
the Selling Shareholder Questionnaire in the form accompanying the Subscription Agreement and return it to the Company together
with the Subscription Agreement. Any subsequent Holder must complete and execute the Selling Shareholder Questionnaire prior to
the due date set forth therein. If any Holder returns his, her or its Selling Shareholder Questionnaire after the stated deadline,
the Company shall not be required to include such Holder’s Registrable Securities in the Registration Statement.

 

(j)     
Notwithstanding anything else set forth herein, the Company may suspend the use of the prospectus that is part of the Registration
Statement (a “Blackout Period”) for valid business reasons (not including avoidance of its obligations hereunder)
or to avoid premature public disclosure of a pending corporate transaction, including pending acquisitions or divestitures of
assets, mergers and combinations and similar events; provided that promptly following the termination of the Blackout Period,
the Company shall notify Holders that the Blackout Period has ended.

 

(k)     
The rights to cause the Company to register Registrable Securities may be assigned by a Holder to a transferee or assignee of
Registrable Securities (for so long as such shares remain Registrable Securities) provided, however, (i) the transfer must
comply with this Registration Rights Agreement; (ii) the transferor shall, within ten (10) days after such transfer, furnish to
the Company written notice of the name and address of such transferee or assignee and the securities with respect to which such
registration rights are being assigned; and (iii) such transferee shall agree to be subject to and bound by all obligations and
restrictions set forth in this Registration Rights Agreement.

 

Section
4      Registration Expenses. All fees and expenses incident to the performance of or
compliance with this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are
sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without
limitation, (a) all registration and filing fees (including, without limitation, fees and expenses) (i) with respect to
filings required to be made with any Trading Market on which the Common Stock is then listed for trading, (ii) in compliance
with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without
limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the
Registrable Securities) and (iii) if not previously paid by the Company in connection with an Issuer Filing, with respect to
any filing that may be required to be made by any broker through which the Holder intends to make sales of Registrable
Securities with FINRA pursuant to the FINRA Rule 2710, so long as the broker is receiving no more than a customary brokerage
commission in connection with such sale; (b) printing expenses (including, without limitation, expenses of printing
certificates for Registrable Securities; (c) messenger, telephone and delivery expenses; (d) fees and disbursements of
counsel for the Company; (e) Securities Act liability insurance, if the Company so desires such insurance; and (f) fees and
expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by
this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with
the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees
and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required
hereunder. In no event shall the Company be responsible for any broker or similar commissions of the Holder or, except to the
extent provided for in the Transaction Agreements, any legal fees or other costs of the Holder.

 

     6

    

    

 

Section
5      Indemnification. 

 

(a)     
Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold
harmless the Holder, the officers, directors, members, partners, agents, investment advisors and employees (and any other Persons
with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title)
of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons
with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title)
of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims,
damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”),
as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in a Registration
Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus,
or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading; or (ii) any violation or alleged violation by the Company of the Securities Act, Exchange
Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under
this Agreement, except to the extent, but only to the extent, that (A) such untrue statements or omissions are based solely upon
information regarding such Holder furnished in writing to the Company by, or on behalf of, such Holder expressly for use therein,
or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such
Prospectus or such form of Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved
Annex A hereto for this purpose and the information provided in writing to the Company by such Holder in its completed
Selling Shareholder Questionnaire in the form attached hereto as Annex B) or (B) in the case of an occurrence of an event
of the type specified in Section 2(c)(iii)-(vi), the use by such Holder of an outdated or defective Prospectus after the Company
has notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of the
Advice contemplated in Section 6(d). The Company shall notify the Holder promptly of the institution, threat or assertion of any
Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware.

 

     7

    

    

 

(b)     
Indemnification by Holder. The Holder shall indemnify and hold harmless the Company, its directors, officers, attorneys,
agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, attorneys, agents or employees of such controlling Persons, to the fullest
extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon:
(i) such Holder’s failure to comply with the prospectus delivery requirements of the Securities Act; or (ii) any untrue
or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or any form of prospectus,
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated therein or necessary to make the statements therein not misleading (A) to the
extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished in writing
by, or on behalf of, such Holder to the Company specifically for inclusion in such Registration Statement or such Prospectus or
(B) to the extent that such information relates to such Holder’s proposed method of distribution of Registrable Securities
and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement (it being understood
that the Holder has approved Annex A hereto for this purpose and the information provided in writing to the Company by
such Holder in its completed Selling Shareholder Questionnaire in the form attached hereto as Annex B), such Prospectus
or such form of Prospectus or in any amendment or supplement thereto or (C) in the case of an occurrence of an event of the type
specified in Section 2(c)(iii)-(vi), the use by such Holder of an outdated or defective Prospectus after the Company has
notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice
contemplated in Section 6(d). In no event shall the liability of any selling Holder hereunder be greater in amount than
the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such
indemnification obligation.

 

(c)     
Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity
is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume
the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all
fees and expenses incurred in connection with defense thereof; provided, that the failure of any Indemnified Party to give such
notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only)
to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to
appeal or further review) that such failure shall have prejudiced the Indemnifying Party.

 

An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1)
the Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed
promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in
any such Proceeding; or (3) the named parties to any such Proceeding (including any impleaded parties) include both such
Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material
conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate
counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written
consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written
consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party
is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims
that are the subject matter of such Proceeding.

 

     8

    

    

 

Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses
to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with
this Section) shall be paid to the Indemnified Party, as incurred, within ten (10) Trading Days of written notice thereof to the
Indemnifying Party, provided that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such
fees and expenses applicable to such actions for which such Indemnified Party is judicially determined to be not entitled to indemnification
hereunder.

 

(d)     
Contribution. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or
insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount
paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying
Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any
other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined
by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material
fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such
Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall
be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other fees or
expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such
fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.

 

The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined
by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred
to in the immediately preceding paragraph. Notwithstanding the provisions of this Section 5(d), no Holder shall be required
to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such Holder
from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission, except in the case
of fraud by such Holder.

 

     9

    

    

 

The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties
may have to the Indemnified Parties.

 

Section
6        Miscellaneous. 

 

(a)
       Remedies. In the event of a breach by the Company or by the Holder of any of
their respective obligations under this Agreement, the Holder or the Company, as the case may be, in addition to being entitled
to exercise all rights granted by law and under this Agreement, including recovery of damages, shall be entitled to specific performance
of its rights under this Agreement. The Company and the Holder agree that monetary damages would not provide adequate compensation
for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that,
in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense
that a remedy at law would be adequate.

 

(b)
       Compliance. The Holder covenants and agrees that it will comply with the prospectus
delivery requirements of the Securities Act as applicable to it in connection with sales of Registrable Securities pursuant to
a Registration Statement.

 

(c)
       Discontinued Disposition. By its acquisition of Registrable Securities, the Holder
agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in and in accordance
with Section 2(c), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement
until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus (as
it may have been supplemented or amended) may be resumed. The Company will use its commercially reasonable best efforts to ensure
that the use of the Prospectus may be resumed as promptly as it practicable. The Company agrees and acknowledges that any periods
during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject to
the provisions of Section 2(b).

 

(d)
       Piggy-Back Registrations. Subject to the permissibility of registering additional
Registrable Securities pursuant to SEC Guidance including Rule 415, if at any time during the Effectiveness Period there is not
an effective Registration Statement covering all of the Registrable Securities and the Company shall determine to prepare and
file with the Commission a registration statement relating to an offering for its own account or the account of others under the
Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act)
or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or
business or equity securities issuable in connection with the stock option or other employee benefit plans, then the Company shall
send to the Holder a written notice of such determination and, if within ten (10) days after the date of such notice, any such
Holder shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable
Securities such Holder requests to be registered; provided, however, that, the Company shall not be required to register any Registrable
Securities pursuant to this Section 6(e) that are eligible for resale pursuant to Rule 144(b)(ii) promulgated under the Securities
Act or that are the subject of a then effective Registration Statement.

 

    10

     

    

 

(e)
       Amendments and Waivers. The provisions of this Agreement, including the provisions
of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof
may not be given, unless the same shall be in writing and signed by the Company and the Holder.

 

(f)
        Notices. Any and all notices or other communications or deliveries required
or permitted to be provided hereunder shall be delivered as set forth in the Subscription Agreement.

 

(g)
       Successors and Assigns. This Agreement shall inure to the benefit of and be binding
upon the successors and permitted assigns of each of the parties and shall inure to the benefit of the Holder. The Company may
not assign its rights (except by merger) or obligations hereunder without the prior written consent of a majority of the Holders.

 

(h)
       Execution and Counterparts. This Agreement may be executed in two or more counterparts,
all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have
been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart.
In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data
file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

(i)
        Governing Law. All questions concerning the construction, validity, enforcement
and interpretation of this Agreement shall be determined in accordance with the provisions of the Subscription Agreement.

 

(j)
        Severability. If any term, provision, covenant or restriction of this Agreement
is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions,
covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or
invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to
achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is
hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions,
covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

(k)
       Headings. The headings in this Agreement are for convenience only, do not constitute
a part of this Agreement, and shall not be deemed to limit or affect any of the provisions hereof.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK;

 SIGNATURE PAGE FOLLOWS] 

 

    11

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.

	 	 	 	 	 	 
	 	Purchaser:	 	Company:	 
	 	 	 	 	 	 
	 	 	 	SANSAL WELLNESS HOLDINGS, INC.	 
	 	 	 	 	 	 
	 	Print Name	 	 	 	 
	 	 	 	 	 	 
	By:	 	 	By:	 	 
	 	Name:	 	 	Name:	 
	 	Title:	 	 	Title:	 

 

    12

     

    

 

ANNEX
A 

 

Plan
of Distribution 

 

The
Selling Shareholder (the “Selling Shareholder”) of the common stock and any of their pledgees (which are accredited
investors (as defined in Regulation D under the Securities Act) or which are in connection with bona fide margin accounts with
a registered broker-dealer or financial institution which is an accredited investor), assignees and successors-in-interest may,
from time to time, sell any or all of their Shares on the OTCQB maintained by OTC Markets, Inc., or any other stock exchange,
market or trading facility on which the shares are quoted or in private transactions. These sales may be at fixed or negotiated
prices. The Selling Shareholder may use any one or more of the following methods when selling Shares:

 

	 	●	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
	 	 	 
	 	●	block trades in which the broker-dealer will attempt to sell the Shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;
	 	 	 
	 	●	purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
	 	 	 
	 	●	an exchange distribution in accordance with the rules of the applicable exchange;
	 	 	 
	 	●	privately negotiated transactions;
	 	 	 
	 	●	settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part;
	 	 	 
	 	●	broker-dealers may agree with the Selling Shareholder to sell a specified number of such Shares at a stipulated price per Share;
	 	 	 
	 	●	through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
	 	 	 
	 	●	a combination of any such methods of sale; or
	 	 	 
	 	●	any other method permitted pursuant to applicable law.

 

The
Selling Shareholder may also sell shares under Rule 144 under the Securities Act, if available, rather than under this Registration
Statement.

 

Broker-dealers
engaged by the Selling Shareholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the Selling Shareholder (or, if any broker-dealer acts as agent for the purchaser of shares,
from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of
an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case
of a principal transaction a markup or markdown in compliance with FINRA IM-2440.

 

    13

     

    

 

In
connection with the sale of the common stock or interests therein, the Selling Shareholder may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the Shares in the course of hedging
the positions they assume. The Selling Shareholder may also sell Shares and deliver these Shares to close out their short positions,
or loan or pledge the Shares to broker-dealers that in turn may sell these Shares. The Selling Shareholder may also enter into
option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities
which require the delivery to such broker-dealer or other financial institution of Shares offered by this prospectus, which Shares
such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect
such transaction).

 

The
Selling Shareholder and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters”
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the Shares purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Shareholder has informed the Company that it does not have any written or oral agreement
or understanding, directly or indirectly, with any person to distribute the Shares. In no event shall any broker-dealer receive
fees, commissions and markups which, in the aggregate, would exceed eight percent (8%).

 

The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the Shares. The Company
has agreed to indemnify the Selling Shareholder against certain losses, claims, damages and liabilities, including liabilities
under the Securities Act.

 

Because
the Selling Shareholder may be deemed to be an “underwriter” within the meaning of the Securities Act, it will
be subject to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder. In addition, any securities
covered by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather
than under this prospectus. There is no underwriter or coordinating broker acting in connection with the proposed sale of these
Shares by the Selling Shareholder.

 

We
agreed to keep this prospectus effective until the earlier of (a) three (3) years from the date of this prospectus or (b) all
of the Shares having been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect.
The Shares will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws.
In addition, in certain states, the Shares may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.

 

    14

     

    

 

Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the Shares may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation
M, prior to the commencement of the distribution. In addition, the Selling Shareholder will be subject to applicable provisions
of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases
and sales of Shares by the Selling Shareholder or any other person. We will make copies of this prospectus available to the Selling
Shareholder and have informed the Selling Shareholder of the need to deliver a copy of this prospectus to each purchaser at or
prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).

 

    15

     

    

 

ANNEX
B

 

SELLING
SHAREHOLDER QUESTIONNAIRE 

 

    16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]